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purposes, prBackground: The objective of this study was to assess an in-house loop-mediated isothermal amplification (LAMP)
platform for malaria parasite detection and identification on species level.
Methods: LAMP primers specific for the human Plasmodium spp., namely, P. falciparum, P. vivax, P. ovale, P. malariae,
and P. knowlesi, as well as genus-specific primers, were tested against a composite gold standard comprising microscopy
from thick and thin blood films, commercial genus-specific Meridian illumigene Malaria LAMP, in-house real-time poly-
merase chain reaction (PCR), and commercial fast-track diagnostics (FTD) Malaria differentiation PCR.
Results: Of the 523 blood samples analyzed, the composite gold standard indicated 243 Plasmodium-species-DNA-
containing samples (46.5%). Sensitivity and specificity of the analyzed genus- and species-specific LAMP primers
were 71.0%–100.0% and 90.8%–100.0%, respectively. The influence of parasitemia was best documented for
P. falciparum-specific LAMP with sensitivity values of 35.5% (22/62) for microscopically negative samples con-
taining P. falciparum DNA, 50% (19/38) for parasitemia ≤50/μL, 84% (21/25) for parasitemia ≤500/μL, and
100% (92/92) for parasitemia >500/μL.
Conclusions: In our hands, performance characteristics of species-specific in-house LAMP for malaria lack reliability
required for diagnostic laboratories. The use of the easy-to-apply technique for surveillance purposes may be considered.
Keywords: Malaria, loop-mediated isothermal amplification, screening, species discrimination, non-endemicIntroduction
Close to the beginning of the new millennium, first approaches
of loop-mediated isothermal amplification (LAMP)-based identifi-
cation of malaria have been described [1]. In the meantime,
numerous publications on this molecular approach have been
published [2–20] and summarized in reviews [21–23]. Many
evaluations were performed with limited sample sizes only
[24–26], but there were also some studies with sample sizes
of several hundred patients [27, 28]. Based on the ongoing
progress in the development of molecular diagnostic tools for
malaria, organizations like the Société de Pathologie Infectieuse
de Langue Française (SPILF) have recommended molecular
tools [29] like LAMP as useful approaches even for initial
screening of patients with suspected malaria. The aim is the
identification of easy-to-implement alternatives to microscopy,
which is largely investigator-dependent, so its reliability is con-
siderably affected by individual factors like the level of training
and professional skills.
Automated LAMP approaches have the potential of use as
easy-to-teach point-of-care testing (POCT) systems, making themng author: Hagen Frickmann, M.D., Department of Microbiology
Hygiene, Bundeswehr Hospital Hamburg, Bernhard Nocht Str. 74,
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(PCR) [30, 31] for the detection of malaria parasites in human
blood samples [21, 32, 33], not only in industrialized countries
but also in tropical areas with restricted laboratory infrastructure.
The easy application of LAMP facilitates the further develop-
ment of malaria-LAMP point-of-care applications, like the com-
bination of LAMP with lateral flow platforms [34–36] or the in
situ application on microscopic slides [37], as well as LAMP
from blood samples on filter papers [38, 39]. Even from body
fluids other than blood like saliva and urine, LAMP-based
detection of Plasmodium spp. DNA has been attempted [40, 41].
Although species-specific identification can be addressed by
LAMP [15, 21], species-specific malaria LAMP is not commer-
cially available so far, and lacking capability for quantitative
assessments remains a disadvantage of the technique. Never-
theless, the LAMP approach can support therapeutic decisions
if other alternatives are not available.
Between April and December 2017, the German National Ref-
erence Center for Tropical Pathogens, Bernhard Nocht Institute
for Tropical Medicine, conducted a study with several hundred
blood samples of patients with suspicion of malaria for the evalu-
ation of a commercial malaria LAMP approach [28]. From those
samples, more than 20% were positive for Plasmodium spp.
DNA. Residual material of nucleic acid extractions were frozenuropean Journal of Microbiology and Immunology 8(2018)4, pp. 112–118
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the evaluation of in-house LAMP primers not only for the identi-
fication of Plasmodium spp. DNA but also for its discrimination
on species level.
In addition, a small number of frozen nucleic acid extrac-
tions of hemolytic samples from patients with suspicion of
malaria were used for a proof-of-principle assessment with
such even more complex sample matrices.
The aim was to set up a LAMP platform based on a semi-
automated, easy-to-apply approach with standardized reagents
and automated interpretation of the results. For this platform,
primers were evaluated regarding their test characteristics with
the above-mentioned, well-characterized set of samples.
Methods
Samples. Residual materials of nucleic acid extractions of
523 fresh ethylenediaminetetraacetic acid (EDTA) blood
samples from patients with clinical suspicion of malaria, i.e., a
subset of a sample set which was assessed during a previous
study at the Bernhard Nocht Institute for Tropical Medicine
between April and December 2017 [28], were included. The
number was chosen to ensure a nearly equal distribution of
positive and negative samples for the case-control-based study
approach. Nucleic acid extraction had been performed with
the EZ1 DNA Blood 200-μL Kit (Qiagen, Hilden, Germany)
as described by the manufacturer and by others [42].
Afterwards, the samples were stored at −80 °C.
The samples were assessed in a blinded manner. This means
that the investigators did not know the results of reference
testing while performing the in-house LAMP analyses.
Reference Testing. Reference testing for the presence of
Plasmodium spp. DNA was based on 3 approaches, i.e.,
microscopy (as an indirect method of proving the presence of
DNA by showing the whole microorganisms), LAMP, and PCR.
From all the EDTA blood samples, the results of Giemsa-stained
[43] thick and thin blood films for Plasmodium spp. including
quantification in line with WHO recommendations, as well as
the results of genus-specific Meridian illumigene Malaria LAMP
(product reference 280925, Meridian Bioscience Inc., Cincinnati,Table 1. Newly designed LAMP primers for this study
Species P. falciparum P
Target gene sal-1
Primer F3 5‘-AAG-CAA-CGG-ATT-GTC-CTG-3‘ 5‘-GCA-TGG-T
Primer B3 5‘-GCA-TCA-TCT-GTC-ATA-CCA-TCA-3‘ 5‘-GAA-GCC-A
Primer forward
inner primer (FIP)
(F1c + F2)
5‘-GCA-ATC-CTC-CTG-ACC-AAT-TCA-
CGC-TGG-AGC-TTC-GAT-AGA-TG-3‘
5‘-AGC-AGT-
TTA-CAC-AGA-
Primer backward
inner primer (BIP)
(B1c + B2)
5‘-ATG-GAG-ATG-GTG-TTG-AGG-
AAG-CAC-ACC-AAC-ATC-CGT-AAT-
ATC-TC-3‘
5‘-GAG-TCA-A
TCT-TCG-CTA-A
Primer LoopF 5‘-CAT-ATG-TCA-GCA-CAA-TGG-
TGA-T-3‘
5‘-TAG-ATG-
T
Primer LoopB 5‘-ACA-CAT-CGT-GTT-ATG-ACA-GT-3‘ 5‘-GTG-GTC-TG
Table 2. LAMP reaction conditions on the Genie II Mk2 system (Amplex Diagn
Software on the LAMP devices
Master mix
Dilution of individual LAMP primers for the mixing of primer mix
Proportions of primer dilutions of the primers
F3 + B3 + BIP + FIP + LF + LB in the primer mix
Composition of LAMP reaction mix 25 μL co
Reaction time
Normalization threshold value
Amplification threshold value
Minimum ratio
Time of first measurementOhio, USA), were available from the previous study [28]. Only
in the case of contradicting results, i.e., discrepant results of
microscopy and illumigene Malaria LAMP, confirmation testing
had been done in line with the previous study protocol [28] with
the molecular reference method of the Bernhard Nocht Institute,
i.e., by genus-specific real-time PCR targeting Plasmodium spp.
(RealStar Malaria PCR kit 1.0, altona Diagnostics Ltd.,
Hamburg, Germany) and by species-specific real-time PCR
targeting P. falciparum, P. knowlesi, P. vivax, P. ovale, and
P. malariae as described elsewhere [31, 42, 44]. In addition, all
nucleic acid extractions were assessed with the FTD Malaria
differentiation PCR (product reference 800613, Fast Track
Diagnostics, Sliema, Malta) according to the manufacturer's
instructions on a Corbett Rotor-Gene 6000 or a Rotor-Gene Q
(Qiagen) from the stored nucleic acid extractions. Of note, this
real-time multiplex PCR discriminates P. falciparum, P. vivax,
P. malariae, and P. ovale.
In-house-LAMP Testing. LAMP primers were designed by
Amplex Diagnostics GmbH (Gars-Bahnhof, Germany) using
the software LAMP Designer V1.10 (PREMIER Biosoft Int.,
Palo Alto, USA). Thereby, 18S rRNA gene-based approaches
as applied by others [15, 45] were discouraged by the
software due to high risks of cross reactions because of
sequence similarities, so other targets were favoured. Newly
designed primers targeted the histone deacetylase gene sal-1
of P. falciparum and P. knowlesi, as well as the dihydrofolate
reductase gene (DHFR) of P. vivax (Table 1). For genus-
specific Plasmodium spp. LAMP, published primers [46]
targeting the mitochondrial sequence PgMt19 were used. As
repeated approaches failed to identify useful LAMP primers
for the merozoite surface protein gene msp-1, the lactate
dehydrogenase gene LD, and the DHFR gene of P. malariae
and P. ovale, previously published LAMP primers for the 18S
rRNA gene of these species were chosen [45] in spite of the
above-mentioned risk of cross-reactions.
The LAMP reactions were run in a Genie II Mk2 system
(Amplex Diagnostics GmbH) using standard conditions, as
detailed in Table 2. Run time was set at 40 min. Temperature
optimum for the primers for Plasmodium spp. was 66 °C for
P. falciparum, P. knowlesi, and P. vivax and 61 °C for P. ovale. knowlesi P. vivax
sal-1 DHFR
GT-AAT-CCT-CCA-G-3‘ 5‘-AGA-ACT-GCA-ATG-CGT-TGA-AC-3‘
CA-GAG-AAT-CCG-3‘ 5‘-CCA-CAC-CTG-TTC-TGT-CTC-C-3‘
CGT-GTG-CAG-GTG-
TAT-CAG-CAC-AGT-G-3‘
5‘-AAG-CTG-AAG-TAC-ACG-AGG-
TCG-CGT-GGC-AGA-AGA-ACA-ACG-3‘
CT-CGT-TCA-CAT-CAC-
TC-GTG-TCG-TAC-AA-3‘
5‘-CCG-GAG-CAC-CTG-CAA-GAT-
TTG-ATG-ATG-TCG-TAT-ATG-ATG-
CCT-AG-3‘
GAG-CTT-CTA-AGC-
GA-AC-3‘
5‘-TCT-TCC-TCT-GCC-TCG-G-3‘
T-ACA-CCT-CCA-TG-3‘ 5‘-CAA-CAG-CCT-GAA-GAT-TAA-GCA-G-3‘
ostics GmbH)
eazyReportTM-IVD-software (Amplex Diagnostics GmbH)
Isothermal master mix ISO-001 (OptiGene Ltd., Horsham, UK)
100 pmol/μL
5 pmol + 5 pmol + 20 pmol + 20 pmol + 10 pmol + 10 pmol
ntaining 2 μL primer mix, 8 μL sample, and 15 μL isothermal master mix
40 min
70,000 arbitrary units
10,000 arbitrary units
0.025
3 min after initiation of the reaction
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Discrimination of Plasmodia by LAMPand P. malariae. A LAMP signal was considered as non-specific
if its melting temperature was beyond the range of the minimum
and maximum melting temperature as observed for truly positive
samples.
Optimum reaction temperatures and detection limits were
defined using serial dilutions of positive control plasmids
(pEX-A2 vector backbone, Eurofins Genomics, Brussels) con-
taining sequence inserts as shown in Supplementary material 1.
Detection limits as detected with the plasmid dilutions are
shown in Table 3.
Case Definitions. Based on the reference diagnostics as
described above, a sample was considered as truly positive for
the presence of DNA of the Plasmodium sp. which was
identified by the assessed in-house-LAMP approach if:
1. either the in-house-LAMP result matched the diagnostic
results from the previous study [28] based on microscopy, Me-
ridian illumigene Malaria LAMP or reference PCR of the
Bernhard Nocht Institute (the latter only performed in the case
of contradicting results between microscopy and illumigene
LAMP as detailed elsewhere [28])
2. or the in-house-LAMP result matched the results of the
FTD Malaria differentiation PCR irrespective of the micro-
scopic results.
If none of these prerequisites was matched, an in-house-
LAMP signal in the expected melting temperature range of
truly positive samples was considered as false positive.
In the case of discrepancy between species identification by
microscopy and species identification by PCR, the result of less
investigator-dependent PCR was accepted as more likely to be true.
A negative in-house-LAMP reaction was considered as
truly negative, if no other approach from the reference diag-
nostics panel indicated a mismatching positive result. If in-
house-LAMP was negative, while microscopy was concor-
dantly negative and only one other molecular approach
showed a positive result, the result of the other molecular ap-
proach was considered as potentially false positive.
The comparator for the LAMP-assessment was defined by
these case definitions. Figure 1 shows the diagnosticFigure 1. Flow chart of the performed diagnostic algorithm with
fresh EDTA blood samples
Table 3. Detection limits of LAMP approaches as defined with positive
control plasmids
LAMP approach Detection limits (calculated copy
numbers per reaction)
Plasmodium genus LAMP 104
P. falciparum LAMP 1
P. vivax LAMP 8
P. malariae LAMP 29
P. ovale LAMP 1
P. knowlesi LAMP 1
114approaches as detailed above. Only illumigene Malaria LAMP
was performed without prior nucleic acid extraction.
Statistics. Sensitivity and specificity were descriptively
demonstrated for this case-control-based assessment using the
software Microsoft Excel version 2007 (Microsoft Corporation,
Redmond, USA).
Proof-of-Principle Assessment with Hemolytic EDTA Blood.
Residual materials from a total of 247 hemolytic EDTA blood
samples of patients with suspicion of malaria, which had
already been used in previous evaluation studies [31, 42], were
included as a proof-of-principle assessment of the LAMP
approach with such complex sample materials. All samples
had been assessed by microscopy as described above and by
SYBR-green-based, species-specific in-house real-time PCR as
described elsewhere [30, 31, 42]. In the case of discrepancy
between microscopy-based and PCR-based species differentia-
tion, the result of less-investigator-dependent PCR was accepted
as more likely to be true. As the available quantities of residual
materials of nucleic acid extractions varied, not all assessments
could be performed for all samples. Figure 2 shows a flow
diagram of the assessments.
Ethics. The blinded use of residual materials from the diagnos-
tic routine for test comparison and evaluation purposes was
allowed by the Ethics Committee of the Medical Association of
Hamburg, Germany (registration number WF-046/16) in line with
national laws.
Results
Proportion of Positive Samples for the Case-Control-
Based Approach. In line with the case definitions above, 243
out of 523 EDTA blood samples (46.5%) were classified as
positive for the presence of Plasmodium spp. DNA. The
identification on species level showed 217 out of 243 samples
containing P. falciparum (89.3%), 17 out of 243 samples
containing P. vivax (7.0%), 6 out of 243 samples containing
P. malariae (2.5%), and 7 out of 243 samples containing P. ovale
(2.9%). P. knowlesi was not detected. Further, there were 3
samples (1.2%) with a mixed infection of P. falciparum and
P. vivax, as well as 1 sample (0.4%) with a mixed infection of
P. ovale and P. falciparum.
Test Characteristics of In-House Malaria LAMP. Genus-
specific in-house malaria LAMP identified 234 out of 243
samples, resulting in a sensitivity of 96.3% (Table 4), comprising
66 samples without parasites in microscopy, 45 at the
microscopic detection limit of ≤50 parasites/μL, 6 between 50
and 99/μL, 30 between 100 and 999/μL, 43 between 1,000 and
9,999/μL, 20 between 10,000 and 99,999/μL, and 33 with ≥1%
infected erythrocytes. The mean time-to-positivity was 15.1 min
(±5.3 min) (standard deviation [SD]), with a median of 14 min.
The 9 false negative samples comprised 5 samples with
parasitemia below the microscopic detection limit, but also 1
sample with P. vivax and 1 with P. ovale with parasitemia ofFigure 2. Flow chart of the performed diagnostic algorithm with
hemolytic EDTA blood samples
Table 4. Sensitivity and specificity of malaria LAMP in truly positive and
negative malaria samples according to the case definitions as presented in
the Materials and Methods section
Sensitivity Specificity
Plasmodium genus LAMP 96.3% (234/243) 98.9% (277/280)
P. falciparum LAMP 71.0% (154/217) 90.8% (278/306)
P. vivax LAMP 82.4% (14/17) 95.3% (482/506)
P. malariae LAMP 100% (6/6) 100% (517/517)
P. ovale LAMP 100% (7/7) 98.8% (511/517)
P. knowlesi LAMP n.a. 92.9% (486/523)
n.a. = not assessable.
Table 5. Sensitivity and specificity of malaria LAMP in truly positive
and negative hemolytic malaria samples according to the case definitions
as presented in the Materials and Methods section
Sensitivity Specificity
Plasmodium genus-specific LAMP 100% (168/168) 91.1% (72/79)
P. falciparum LAMP 92.0% (126/137) 99.1% (107/108)
P. vivax LAMP 100% (16/16) 100% (230/230)
P. malariae LAMP 100% (3/3) 99.2% (243/245)
P. ovale LAMP 100% (8/8) 95.0% (228/240)
P. knowlesi LAMP n.a. 98.4% (242/246)
n.a. = not assessable. Different total numbers of assessments are due to
varying volumes of available residual sample material, not allowing for
performing all assays with all samples.
H. Kollenda et al.≤50/μL for each sample, and 2 P. falciparum-positive samples
with parasitemia of 112/μL and 1%, respectively. Of note, the
latter 2 false negative results were not reproducible, when the
assessments were exemplarily repeated after unblinding at the
end of the study. In addition, 3 false positive signals were
detected, resulting in specificity of 98.9% (277/280) (Table 4).
The mean time-to-positivity was 20.8 min (±18.2 min) with a
median of 23 min. In addition, there were 26 non-specific
LAMP-signals outside the temperature range of positive samples,
which was between 82.95 °C and 83.93 °C. The mean time-to-
positivity was 3.9 min (±6.2 min), with a median of 1.5 min.
P. falciparum-specific LAMP showed sensitivity of 71.0%,
correctly identifying 154 out of 217 P. falciparum positive sam-
ples (Table 4). There was a marked influence of parasitemia.
While only 35.5% (22/62) samples were positive by LAMP in
the case of submicroscopic positive samples, the sensitivity was
50% (19/38) for samples with parasitemia ≤50/μL and 84%
(21/25) for samples with parasitemia between 51/μL and
500/μL. All samples with higher parasitemia (92/92) were
positive in LAMP. Time-to-positivity in truly positive samples
was 27.3 (±6.1) min with a median of 26.0 min. The specificity
was 90.8% (278/306) with 2 false positive results in samples
with P. ovale, 1 false positive result in a sample with P. vivax,
and 25 false positive results in negative samples. Time-to-
positivity in false positive samples was 32.0 (±13.2) min with
a median of 38.5 min. There was a wide melting temperature
range between 80.57 °C and 86.11 °C for truly positive samples,
which was, however, associated with only 3 non-specific reac-
tions with negative samples outside this range. Time-to-positivity
in those samples with non-specific signals was 1.6 (±0.1) min
with a median of 1.5 min.
P. vivax-specific LAMP identified 82.4% (14/17) P. vivax-
positive samples (Table 4). The failed reactions comprised 1
submicroscopically positive sample and 2 out of 5 (40%)
samples with parasitemia ≤50/μL. All positive samples with
higher parasitemia were correctly identified. Time-to-positivity
of truly positive samples was 17.2 (±10.3) min with a median
of 12.4 min. The melting temperature of positive samples
ranged between 86.04 °C and 87.01 °C. Within this temperature
range, 24 false positive results were detected, comprising
15 samples with P. falciparum and 9 negative samples. Time-
to-positivity in false positive samples was 36.4 (±4.2) min with
a median of 38.1 min. The specificity was 95.3% (482/506)
(Table 4). The observed 31 non-specific LAMP signals outside
this temperature range comprised 18 samples with P. falciparum
and 13 negative samples. Time-to-positivity in the case of non-
specific signals was 31.1 (±13.1) min with a median of 37.0 min.
P. malariae-specific LAMP showed a sensitivity of 100%
(6/6) and specificity of 100% (517/517). Parasitemia of posi-
tive samples was low, ranging from submicroscopic parasite
densities to 360/μL. The melting temperature range was
85.12 °C to 85.82 °C. Time-to-positivity in truly positive sam-
ples was 19.7 (±2.1) min with a median of 19.9 min. A total
of 7 non-specific signals were observed, comprising 4 samples
with P. falciparum and 3 negative samples. Time-to-positivityin the case of non-specific signals was 28.0 (±15.9) min with a
median of 39.3 min.
P. ovale-specific LAMP was characterized by 100% sensi-
tivity (7/7) with 98.8% specificity (511/517). Parasitemia in
the positive samples ranged from <50/μL to 20,900/μL. Time-
to-positivity in truly positive samples was 16.9 (±9.9) min
with a median of 13.3 min. False positive results within the
melting temperature range of truly positive samples between
84.13 °C and 85.22 °C were observed for 5 samples with
P. falciparum and 1 negative sample. Time-to-positivity in
false positive samples was 29.5 (±8.1) min with a median of
28.5 min. In addition, 13 samples comprising 7 negative sam-
ples and 4 samples with P. falciparum, as well as 1 sample with
P. vivax and 1 sample with P. malariae, showed non-specific
signals. Time-to-positivity in samples with non-specific signals
was 23.4 (±17.3) min with a median of 32.8 min.
As P. knowlesi was not observed within the assessed sam-
ples, a sensitivity value cannot be defined. Assuming a melt-
ing temperature range of 84 °C to 87 °C based on the melting
temperature of the positive control plasmids between 85 °C
and 86 °C ± 1 °C, a total of 37 false positive signals were ob-
served. These comprised 20 samples with P. falciparum, 1
sample with P. vivax, and 16 negative samples, resulting in a
specificity of 92.9% (486/523). Time-to-positivity in false pos-
itive samples was 36.1 (±8.3) min with a median of 38.8 min.
Outside this hypothetical melting temperature range, 17 non-
specific signals were observed, comprising 12 samples with
P. falciparum, 3 samples with P. vivax, and 2 negative sam-
ples. Time-to-positivity in the case of non-specific signals was
11.2 (±13.8) min with a median of 4.0 min.
Comparison of LAMP and Microscopy. If only
microscopically positive samples were counted, sensitivity
would change to 97.7% (173/177) for Plasmodium genus,
86.6% (131/153) for P. falciparum, 87.5% (14/16) for P. vivax,
100% (5/5) for P. malariae, and 100% (6/6) for P. ovale.
Evaluation of LAMP with Hemolytic Blood Samples. To
assess malaria LAMP with the more complex sample matrices
of hemolytic blood, a small proof-of-principle assessment was
performed. Among a total of 168 malaria-positive hemolytic
EDTA blood samples with parasitemia from submicroscopic
levels up to 10%, all showed a positive signal in the
Plasmodium genus-specific malaria LAMP (Table 5). For 1
sample, positivity was confirmed neither by microscopy nor by
species-specific SYBR-green PCR but by commercial genus-
specific PCR (altona Diagnostics) only. The mean time to
detect a positive result was 11.1 (±3.3) min, and the median
time was 10.5 min. The melting temperature range for positive
samples was between 82.48 °C and 85.15 °C. Among 79
negative samples, 7 false positive results were detected,
resulting in specificity of 91.1% (72/79) (Table 5). The time-to-
positivity for the false positive signals was 16.5 (±16.1) min
with a median of 13.3 min. In addition, 1 non-specific signal
was observed 1.8 min after the onset of measuring.115
Discrimination of Plasmodia by LAMPFocusing on P. falciparum-specific LAMP, 126 out of 137
(92.0%) P. falciparum-positive hemolytic samples were cor-
rectly identified (Table 5). Parasitemia in the 11 false negative
samples comprised 7 microscopically negative samples, 3
samples with parasitemia ≤50/μL, and 1 sample with parasite-
mia of 64/μL. The time-to-positivity for truly positive samples
was 25.3 (±4.0) min with a median of 25.0 min. In contrast,
specificity was 99.1% with 1 false positive signal in a sample
without plasmodia DNA as detected by the reference methods
that became positive 29.5 min after the onset of measuring
(Table 5). In another negative sample, a non-specific signal
outside the observed melting temperature range between
81.58 °C and 82.88 °C for positive hemolytic samples was ob-
served after 2.8 min.
P. vivax-specific LAMP-primers correctly identified 100%
of P. vivax-positive hemolytic blood samples (16/16) (Table 5)
with parasitemia ranging from submicroscopic parasite density
up to 19,000/μL. The observed melting temperature range for
the hemolytic samples was 85.72 °C to 86.41 °C. The time-to-
positivity for the truly positive samples was 12.5 (±1.7) min
with a median of 12.5 min. No false positive signals within
the melting temperature range were observed, resulting in
100% specificity (230/230) (Table 5). However, 18 non-specific
signals were detected outside this range, comprising 12 samples
with P. falciparum, 5 negative samples, and 1 sample with
P. ovale. The time-to-positivity for the non-specific signals was
38.5 (±1.6) min with a median of 39.4 min.
Focusing on P. ovale-specific LAMP, 100% of hemolytic
blood samples (8/8) with P. ovale were correctly identified
(Table 5). Parasite density ranged from submicroscopic parasi-
temia to 714/μL, the melting temperature of positive samples
was between 84.65 °C and 85.02 °C. The time-to-positivity
for the truly positive samples was 18.0 (±2.9) min with a me-
dian of 17.9 min. A total of 12 false positive signals were ob-
served, which occurred in samples with P. falciparum without
exemption, resulting in specificity of 95% (228/240) (Table 5).
The time-to-positivity for the false positive samples was 29.2
(±6.0) min with a median of 29.0 min. Further, 17 non-specific
signals were observed outside the melting temperature range of
truly positive samples. Again, this phenomenon was only ob-
served in samples with P. falciparum. The time-to-positivity for
the samples with non-specific signals was 32.8 (±6.6) min with a
median of 35.8 min.
For P. malariae-specific LAMP-primers, a sensitivity of
100% (3/3) was observed for the assessed hemolytic samples
(Table 5). Parasitemia ranged from 1400/μL to 2640/μL. The
melting temperature of the truly positive samples ranged from
84.82 °C to 86.02 °C. The time-to-positivity for the truly posi-
tive samples was 21.0 (±0.9) min with a median of 21.3 min.
Two false positive samples were observed, comprising 1 nega-
tive sample, which became positive 3.8 min after the onset of
measuring, and 1 sample with P. falciparum, which became posi-
tive after 24 min. The resulting specificity was 99.2% (243/245)
(Table 5). In addition, 26 non-specific signals were observed in
14 negative samples and 9 samples with P. falciparum, as well
as in 1 sample with P. vivax, 1 sample with P. ovale, and 1
sample containing unidentified Plasmodium spp. The time-to-
positivity for the non-specific signals was 5.2 (±4.5) min with a
median of 4.5 min.
P. knowlesi-positive hemolytic samples were not available, not
allowing for calculations of sensitivity of P. knowlesi-specific
LAMP-primers. Assuming a likely melting temperature range be-
tween 84 °C and 87 °C based on the values measured with the
positive control plasmid ±1 °C, 4 false positive samples were ob-
served, comprising 2 samples with P. falciparum, 1 sample with
P. vivax, and 1 negative sample. Accordingly, the observed speci-
ficity for hemolytic samples was 98.4% (242/246) (Table 5). The116time-to-positivity for the false positive samples was 39.5 (±0.4)
min with a median of 39.5 min.
Discussion
Other than for genus-specific LAMP for malaria [28], com-
mercial products for species-specific malaria LAMP are still
missing so far. The present study was performed to assess the
diagnostic characteristics of genus- and species-specific in-
house LAMP for the detection of malaria after automated
nucleic acid extraction from fresh EDTA blood, as well as
from hemolytic blood samples. As suggested by previous as-
sessments [24–28, 46], genus-specific LAMP targeting mito-
chondrial DNA shows very good sensitivity and specificity of
more than 98% each [28] in preparations from fresh EDTA
blood samples compared with other microscopic and molecu-
lar diagnostic approaches. However, the observed failed
genus-specific malaria LAMP reaction in a sample with high
parasitemia of 1% P. falciparum is bothersome. Although this
finding was not reproducible after unblinding of the study, this
fact does not solve the problem that the diagnosis might have
been missed in a real-life diagnostic setting. Next to this, the
specificity of the assessed genus-specific LAMP approach con-
siderably drops if appropriate pre-analytic conditions cannot be
maintained, and hemolytic samples have to be assessed. Any-
way, even in fresh EDTA samples, a recently assessed commer-
cial genus-specific malaria LAMP approach scored better [28]
than the here assessed approach. Considering the fact that this
commercial approach [24–28] did not even require sophisticated
nucleic acid extraction procedures and could be operated as a
real point-of-care system in this way, the genus-specific malaria
LAMP approach which was used in this study did not challenge
the present state of the art. Other study groups have introduced
malaria LAMP approaches without nucleic acid extraction as
well [1, 47].
Compared with recent reviews of the literature [21–23],
both the sensitivity and the specificity of the newly developed
and evaluated LAMP primers for P. falciparum and P. vivax
targeting chromosomal genes fell short of our expectations.
The relatively high proportion of samples with submicroscopic
and very low parasitemia in this study is a likely reason for
the observed low sensitivity. For both species-specific LAMP
approaches, a clear association between parasitemia and likeli-
hood of observing a positive LAMP signal was detected. Due
to the relatively high numbers of samples with low parasite
density of P. falciparum, the phenomenon is especially well
documented for P. falciparum LAMP. The reduced reliability
of P. falciparum LAMP up to a parasite density of 500/μL is
bothersome, as the LAMP approach does not score better than
traditional immunochromatographic rapid diagnostic test
(RDT) devices in this way. The observed specificity was dis-
satisfying as well, as it leads to interpretation problems in the
case of positive test results in low-endemicity settings. Inter-
estingly, both sensitivity and specificity were better in hemo-
lytic blood. The latter phenomenon could be explained by
increased inhibition in the hemolytic blood [48], making the
detection of late non-specific LAMP signals less likely.
For P. malariae and P. ovale, we had to establish LAMP ap-
proaches targeting the 18S ribosomal RNA gene as described
[15, 45], although this choice was discouraged by the primer
design software due to the likelihood of cross-reactions (data
not shown). We did so because attempts with other genes had
failed as mentioned above. In initial test series (data not
shown), the designs by Han et al. [45] showed less cross-bind-
ing and non-specific reactions than the designs by Lau et al.
[15] and were therefore chosen. Both with fresh EDTA blood
and hemolytic blood, the LAMP primers targeting the 18S
H. Kollenda et al.rRNA gene of P. malariae scored very well with sensitivity and
specificity of >99% each. For the P. ovale LAMP approach,
however, the expected specificity problems were observed with
increased abundance in the hemolytic samples. Cross-reactions
with P. falciparum were the most frequent reasons for false pos-
itive signals with the P. ovale LAMP primers targeting the
18S rRNA gene. Due to such problems regarding the identi-
fication of reliable species-specific LAMP primers, other au-
thors suggested on-site-sequencing of LAMP-products by
MINIONTM nanopore sequencing [49]. Due to the costs of
such an approach, this is, however, an approach of mere aca-
demic value at present.
Due to the complete absence of P. knowlesi in the assessed
samples, no sensitivity values for the P. knowlesi-specific
primers could be calculated. However, based on a likely
spread around the melting temperature of the positive control
plasmid, a considerably number of false positive results could
be identified. As already observed for P. falciparum- and
P. vivax-specific LAMP, the frequency of false positive results
was lower in hemolytic materials than in nucleic acid extrac-
tions of fresh EDTA blood samples. Studies in endemic areas
of P. knowlesi are necessary to thoroughly evaluate the per-
formance of LAMP with blood samples of patients with
P. knowlesi [50–53].
In summary, the assessed LAMP approaches both for genus-
and species-specific identification of Plasmodium spp. did not
achieve the better performance characteristics as described by
others [15, 27, 32, 54, 55] with sensitivity ranging from 94.8%
to 100% and specificity ranging from 96.7% to 100% in previous
studies [15, 27, 54]. Newly developed LAMP protocols targeting
chromosomal genes were associated with sensitivity problems
in samples with submicroscopic and very low parasitemia.
However, incidental failures of the LAMP reaction as ob-
served for the genus-specific approach with an individual
highly parasitemic sample limit the diagnostic value of the in-
troduced LAMP approach as well.
Considering the limitations as observed in this study, the
easy-to-apply diagnostic approach may theoretically serve as a
tool for epidemiologic screenings at population level in areas
where sophisticated diagnostic strategies cannot be applied
[56–62]. In such settings, the known performance characteris-
tics of the described LAMP schemes can be used to calculate
the true prevalence in the assessed populations based on diag-
nostic accuracy-adjusted methods [63]. This is well in line
with previous recommendations for the use of malaria-specific
LAMP for surveillance purposes [64, 65].
For diagnostic purposes, however, the observed perfor-
mance characteristics especially of species-specific malaria
LAMP targeting chromosomal genetic elements were dissatis-
fying. Our approach clearly failed to overcome the obstacles
which prevented the commercial availability of species-spe-
cific malaria LAMP so far. Our experience may be of value
for other groups working on the establishing of reliable spe-
cies-specific malaria LAMP approaches by clearly demonstrat-
ing the limitations that we observed.
Conclusions
The observed species-specific in-house malaria LAMP pro-
tocols showed limitations regarding sensitivity and specificity,
which make them unsuitable for use in the diagnostic routine
setting. The genus-specific approach showed higher reliability
but did not score better than an available commercial platform,
which works as a real point-of-care approach without previous
nucleic acid extraction [28]. If any, one might consider the use
of our described easy-to-teach and easy-to-apply procedure as
an option for surveillance screenings on population level inresource-limited settings, if diagnostic accuracy-adjusted
methods are applied to calculate the true prevalence based on
the known test characteristics.
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